37 related articles for article (PubMed ID: 19394201)
21. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
22. Tricyclic nucleoside analogues as antiherpes agents.
Golankiewicz B; Ostrowski T
Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
[TBL] [Abstract][Full Text] [Related]
23. Separation methods for acyclovir and related antiviral compounds.
Loregian A; Gatti R; Palù G; De Palo EF
J Chromatogr B Biomed Sci Appl; 2001 Nov; 764(1-2):289-311. PubMed ID: 11817033
[TBL] [Abstract][Full Text] [Related]
24. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
25. [Modified nucleoside phosphates as precursors of antineoplastic and antiviral compounds in a cell].
Arzumanov AA; Diatkina NB
Bioorg Khim; 1996; 22(10-11):777-94. PubMed ID: 9036839
[No Abstract] [Full Text] [Related]
26. A perspective on antiviral resistance.
Griffiths PD
J Clin Virol; 2009 Sep; 46(1):3-8. PubMed ID: 19615937
[TBL] [Abstract][Full Text] [Related]
27. Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules.
Meier C; Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):282-92. PubMed ID: 16735066
[TBL] [Abstract][Full Text] [Related]
28. Towards evidence based medicine for paediatricians. Does oral aciclovir improve clinical outcome in immunocompetent children with primary herpes simplex gingivostomatitis?
Hudson B; Powell C
Arch Dis Child; 2009 Feb; 94(2):165-7. PubMed ID: 19158139
[No Abstract] [Full Text] [Related]
29. [Development of drugs with antiherpetic activity].
Lin JW; Chen QM; Zhou HM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jan; 41(1):60-2. PubMed ID: 16620633
[No Abstract] [Full Text] [Related]
30. A new route of synthesis of estetrol.
Warmerdam EG; Visser M; Coelingh Bennink HJ; Groen M
Climacteric; 2008; 11 Suppl 1():59-63. PubMed ID: 18464024
[No Abstract] [Full Text] [Related]
31. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
32. Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents.
Wentland MP; Perni RB; Dorff PH; Brundage RP; Castaldi MJ; Carlson JA; Bailey TR; Aldous SC; Carabateas PM; Bacon ER; Kullnig RK; Young DC; Woods MG; Kingsley SD; Ryan KA; Rosi D; Drozd ML; Dutko FJ
Drug Des Discov; 1997 May; 15(1):25-38. PubMed ID: 9332829
[TBL] [Abstract][Full Text] [Related]
33. [Anti alpha-herpesvirus drugs].
Koshizuka T; Suzutani T
Nihon Rinsho; 2012 Apr; 70(4):558-63. PubMed ID: 22568134
[TBL] [Abstract][Full Text] [Related]
34. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
35. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy.
De Clercq E; Field HJ
Br J Pharmacol; 2006 Jan; 147(1):1-11. PubMed ID: 16284630
[TBL] [Abstract][Full Text] [Related]
36. Human herpes simplex virus: life cycle and development of inhibitors.
Kukhanova MK; Korovina AN; Kochetkov SN
Biochemistry (Mosc); 2014 Dec; 79(13):1635-52. PubMed ID: 25749169
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
